You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 34015 results
  1. SBIR Phase I:Novel development of a pediatric Magnetic Resonance Imaging (MRI) scanner

    SBC: ADIALANTE L.L.C.            Topic: IH

    This Small Business Innovation Research (SBIR) Phase I project focuses on the development of techniques that will facilitate the design and development of affordable, compact, and patient-friendly magnetic resonance imaging (MRI) systems. MRI systems are the preferred modality for a range of imaging types, notably pediatrics, due to their superior diagnostic capabilities, high resolution, and mini ...

    SBIR Phase I 2023 National Science Foundation
  2. SBIR Phase I: Delivering Confidence and Reliability in Thermal Batteries for Utilities Using an Aggressively Cycled Test Loop for Pumps, Pipes, Joints and Valves

    SBC: THERMAL BATTERY CORPORATION            Topic: EN

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is focused on developing an energy storage technology that stores electricity as heat and converts its back to electricity whenever needed using thermophotovoltaics (TPV). If successful, the innovation will help transition the United States (US) towards a fully renewable electrical grid. The c ...

    SBIR Phase I 2023 National Science Foundation
  3. SBIR Phase II:Clinical scale and testing of the first virus-free precision gene edited cell therapy for veterinary oncology

    SBC: LifEngine Animal Health Laboratories Incorporated            Topic: BM

    The broader impact of this Small Business Innovation Research (SBIR) Phase II project is the development of a commercially-ready cell engineering platform that will enable a curative therapy for cancer in the veterinary market.An estimated 250,000 dogs get B cell lymphoma every year. Chimeric Antigen Receptor (CAR)-T cell therapy offers hope for a treatment for this disease. The project platform f ...

    SBIR Phase II 2023 National Science Foundation
  4. SBIR Phase II:Gaze-independent contactless autorefractor for self-serve eye exam kiosk.

    SBC: 123 See, Inc.            Topic: DH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to improve access to vision care and eyeglasses for all Americans through a self-serve, rapid vision exam kiosk for retail stores and public spaces. An estimated 175 million Americans suffer from blurry vision, of which 30 million live without eyeglasses. By partnering with retailers, phar ...

    SBIR Phase II 2023 National Science Foundation
  5. SBIR Phase II:Meat substitutes combining cultured animal cells with plant-based fibers

    SBC: TENDER FOOD, INC.            Topic: BT

    The broader impact of this Small Business Innovation Research (SBIR) Phase II project is the advancement of sustainable and ethically produced meat alternatives. Most people have tried or know someone who has tried plant-based meats. Opinions vary but most people acknowledge that meats made from animals are not accurately recreated using plants, especially for unprocessed whole cuts like chicken b ...

    SBIR Phase II 2023 National Science Foundation
  6. STTR Phase II:Stem Cell Delivery in Microscopic Hydrogel Droplets for Faster and More Complete Healing of Equine Tendon and Ligament Injuries

    SBC: CellDrop Inc            Topic: PT

    The broader impact of this Small Business Technology Transfer (STTR) Phase II project involves continued development of technology to extend the therapeutic window of cell-based tissue regeneration therapies. This technology could significantly enhance the scientific understanding of cellular therapies and enable the healing of injuries more rapidly and less invasively than current techniques. A s ...

    STTR Phase II 2023 National Science Foundation
  7. Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs.

    SBC: GEL4MED, INC.            Topic: 200

    Project Summary/AbstractDFUs will affect more than 30% of diabetic patients within their lifetime and costs the US healthcare system over $20 billion annually. Many DFUs fail to heal effectively and require extensive medical intervention. Nearly 50% of DFUs worsen to “tunnel” into deep tissues involving tendons and bones (DTU-DFUs). When this happens, DFUs are susceptible to severe complicatio ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel Technology to Disseminate WOOP (Wish, Outcome, Obstacle, Plan) to Dementia Caregivers

    SBC: BORROW MY GLASSES LLC            Topic: NIA

    1 Approximately 6.5 million Americans aged 65 and older live with dementia, supported by more than 11 million2 unpaid family caregivers. These numbers are projected to rise exponentially in the coming decades fueling the3 need to develop scalable ways to support dementia caregivers. The need to empower dementia caregivers to4 continue providing care while maintaining their own health and well-bein ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients

    SBC: PASCALL Systems, Incorporated            Topic: NIA

    Each day, more than 100,000 patients undergo general anesthesia in the United States. The current practice of general anesthesia is prone to over-sedating patients, either due to the lack of brain monitoring or using brain monitors with inaccurate indices. Over-sedation (at 28% incidence) contributes to perioperative neurocognitive disorders (PNDs) in elderly population (≥65yrs). The cost of PND ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. First-in-class TREM-1 inhibitors for neovascular retinal diseases

    SBC: SIGNABLOK, INC.            Topic: 100

    Project Summary/Abstract Retinal neovascularization (RNV) is a major cause of vision loss in retinopathy of prematurity (ROP), diabetic retinopathy (DR) and retinal vein occlusion. In the US, about 16,000 of premature infants are affected by ROP annually and about 4.1 million adults years have DR. Complications of conventional treatments suggest an unmet need for new therapies. The long-term objec ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government